| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 17.73▲ | 17.92▼ | 17.88▼ | 17.47▲ | 17.92▼ |
| MA10 | 17.85▼ | 17.90▼ | 17.86▼ | 17.34▲ | 19.21▼ |
| MA20 | 17.94▼ | 17.91▼ | 17.86▼ | 17.81▼ | 18.94▼ |
| MA50 | 17.91▼ | 17.65▲ | 17.36▲ | 19.28▼ | 17.19▲ |
| MA100 | 17.90▼ | 17.38▲ | 17.47▲ | 18.83▼ | 14.90▲ |
| MA200 | 17.83▼ | 17.52▲ | 18.47▼ | 17.71▲ | 14.89▲ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.035▼ | -0.033▼ | -0.038▼ | 0.095▲ | -0.418▼ |
| RSI | 40.402▼ | 48.179▼ | 52.373▲ | 43.978▼ | 47.811▼ |
| STOCH | 9.127▼ | 72.071 | 36.351 | 44.512 | 23.712 |
| WILL %R | -69.444 | -55.556 | -77.143▼ | -40.000 | -77.758▼ |
| CCI | -59.817 | -81.144 | -75.330 | 86.567 | -87.251 |
|
Wednesday, April 24, 2024 10:35 AM
Kiniksa plans to develop abiprubart for treatment of Sjogren's syndrome, with phase 2b trial expected to start in the second half. Read more on KNSA stock here.
|
|
Wednesday, April 24, 2024 06:00 AM
Kiniksa Pharmaceuticals, Ltd. beats earnings expectations. Reported EPS is $-0.00025, expectations were $-0.14.
|
|
Tuesday, April 23, 2024 12:53 PM
KNSA stock results show that Kiniksa Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.More From InvestorPlace The #1 AI Investment ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 25/04/24 | 17.59 | 18.09 | 17.55 | 17.79 | 229,308 |
| 24/04/24 | 18.21 | 18.61 | 17.64 | 17.86 | 443,785 |
| 23/04/24 | 17.10 | 18.14 | 17.04 | 17.68 | 611,899 |
| 22/04/24 | 17.10 | 17.43 | 16.87 | 17.095 | 361,220 |
| 19/04/24 | 16.87 | 17.145 | 16.56 | 16.91 | 375,954 |
| 18/04/24 | 16.99 | 17.05 | 16.80 | 16.88 | 409,188 |
| 17/04/24 | 17.54 | 17.57 | 16.92 | 16.95 | 389,307 |
| 16/04/24 | 17.38 | 17.61 | 17.33 | 17.46 | 304,967 |
| 15/04/24 | 17.19 | 17.54 | 17.19 | 17.44 | 314,106 |
| 12/04/24 | 17.71 | 17.71 | 17.13 | 17.29 | 257,002 |
|
|
||||
|
|
||||
|
|